These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 20050293)

  • 1. In-vivo assessment of application of folinic acid and botulinum toxin A in cleft lip surgical defects.
    Shiva A; Soltani P; Moaddabi A; Yazdian R; Saeedi M; Mozoun Z; Esfandpour A; Rengo C; Namdar P; Spagnuolo G
    Orthod Craniofac Res; 2024 Jun; 27 Suppl 1():115-121. PubMed ID: 38459796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lidocaine incorporation (without epinephrine) on pain and 2-week complications of botulinum toxin: a double-blind randomized placebo-controlled clinical trial.
    Sarkarat F; Bagheri D; Kahali R; Fateh A; Rakhshan V
    Sci Rep; 2023 May; 13(1):7812. PubMed ID: 37183235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison and overview of currently available neurotoxins.
    Walker TJ; Dayan SH
    J Clin Aesthet Dermatol; 2014 Feb; 7(2):31-9. PubMed ID: 24587850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study.
    Gassner HG; Sherris DA
    Mayo Clin Proc; 2000 Jul; 75(7):701-4. PubMed ID: 10907385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis.
    Lee JM; Choi KH; Lim BW; Kim MW; Kim J
    J Plast Reconstr Aesthet Surg; 2015 Jan; 68(1):71-8. PubMed ID: 25444667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A reconstituted in lidocaine with epinephrine for facial rejuvenation: results of a participant satisfaction survey.
    Kim A; Jung J; Pak A
    Cutis; 2013 Jul; Suppl():13-8. PubMed ID: 24308152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term sequelae treatment of peripheral facial paralysis with botulinum toxin type A: Repartition and kinetics of doses used.
    Risoud M; Aljudaibi N; Duquennoy-Martinot V; Guerreschi P
    Ann Chir Plast Esthet; 2016 Feb; 61(1):10-5. PubMed ID: 25953657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Simultaneous injection of lidocaine improves predictability of effect of botulinum toxin].
    Haubner F
    Laryngorhinootologie; 2009 Dec; 88(12):764. PubMed ID: 20050293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum Toxin Type A to Improve Facial Symmetry in Facial Palsy: A Practical Guideline and Clinical Experience.
    de Sanctis Pecora C; Shitara D
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33670477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electromyographic guidance in injecting botulinum toxin.
    Klein AW; Mantell A
    Dermatol Surg; 1998 Nov; 24(11):1184-6. PubMed ID: 9834737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives.
    Lowe NJ
    Dermatol Surg; 1998 Nov; 24(11):1216-8. PubMed ID: 9834741
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.